TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.
about
Sumoylation pathway is required to maintain the basal breast cancer subtypeLinks between cancer stem cells and epithelial-mesenchymal transitionRegulation of epithelial-mesenchymal transition through SUMOylation of transcription factorsRegulation of epithelial-mesenchymal transition through epigenetic and post-translational modificationsTFAP2A is a component of the ZEB1/2 network that regulates TGFB1-induced epithelial to mesenchymal transitionArray-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cellsBioinformatic analysis of cis-regulatory interactions between progesterone and estrogen receptors in breast cancer.A novel animal model for locally advanced breast cancer.Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.Identification of chromatin accessibility domains in human breast cancer stem cells.Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast CancerInhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer.Information-dependent enrichment analysis reveals time-dependent transcriptional regulation of the estrogen pathway of toxicity.Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal CarcinomasTFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation.Altered Transcriptional Control Networks with Trans-Differentiation of Isogenic Mutant-KRas NSCLC Models.TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.Transcriptional regulation by the AP-2 (TFAP2) family of transcription factorsTransCONFIRM: Identification of a Genetic Signature of Response to Fulvestrant in Advanced Hormone Receptor-Positive Breast Cancer.Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations.Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing.MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
P2860
Q24297866-500915D4-3846-4D0A-B987-E6ADD68D08E3Q27004529-C0DC1DB5-BE75-4995-9A0A-A54452531123Q27010433-ED320735-7231-4368-A7BF-B96037F2351AQ28076697-5D5E0E9C-4FA3-4220-B9EB-FE1468039A37Q33568354-4ECF1A34-893C-47B8-8123-46B632D0C973Q34365770-C4A9B311-A21C-439B-8307-48D46D6CE5CBQ34568706-E2D746AC-2E80-487F-8C8B-62055FD21020Q35586380-A4E67B05-7C6D-4C63-B811-81522561CEF8Q35695796-8F646034-AB25-42B2-AC9A-3633CA5F9D33Q36069105-9AFD6D6F-8D66-4BEF-8B8E-B6C3E03B5458Q36665258-E08DB84B-13C2-491D-B296-D03A728623C9Q37028506-78EE6D96-15DE-4C45-806E-BA1C23DA812CQ37214094-0B8D2AA2-CEA4-41C6-A98A-6B634062FEA9Q37707145-8DFF6D35-0FC5-436C-ADE5-84D6AE1306F3Q37719183-E0E73900-D81A-4BD5-A8A2-F57B5101A1DAQ38727673-970B376F-F86A-4C96-BE00-654DCE407745Q38748274-C8392FB0-5757-4050-A289-D171A79F989CQ41582923-89775B57-3C34-4EF2-9C3A-3CB58A2158EBQ41598833-E3C7C1AE-6DD4-4F14-942B-4515FC9AB1D1Q45316793-CC4E748B-2F28-4DFE-886B-E8A87FE1A998Q49537165-D79D5381-A6C5-4034-85AE-E7A034BC475AQ49569565-AEFEEFD3-019F-4034-9AF5-BA5C0988E61BQ50040433-82F014CC-CBD2-47A3-A603-2C98F0902533Q52604141-B5F404CE-3BA7-4B9A-B122-59FAC86435C0Q52609396-2CA82C9E-3F9A-444B-B2B7-7A05FCA73058
P2860
TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
TFAP2C governs the luminal epi ...... evelopment and carcinogenesis.
@ast
TFAP2C governs the luminal epi ...... evelopment and carcinogenesis.
@en
type
label
TFAP2C governs the luminal epi ...... evelopment and carcinogenesis.
@ast
TFAP2C governs the luminal epi ...... evelopment and carcinogenesis.
@en
prefLabel
TFAP2C governs the luminal epi ...... evelopment and carcinogenesis.
@ast
TFAP2C governs the luminal epi ...... evelopment and carcinogenesis.
@en
P2093
P2860
P50
P356
P1433
P1476
TFAP2C governs the luminal epi ...... evelopment and carcinogenesis.
@en
P2093
A K Olivier
G W Woodfield
L S White-Baer
M V Bogachek
P M Spanheimer
Y Q O'Malley
P2860
P2888
P304
P356
10.1038/ONC.2013.569
P407
P577
2014-01-27T00:00:00Z
P5875
P6179
1049831512